论文部分内容阅读
心源性休克为内科急重症,病死率高。尤其急性心肌梗塞患者发生心源性休克占10—20％,其死亡率比无休克者高4—6倍,是当前冠心病研究的重点之一。以前用多巴胺,间羟胺或多巴酚丁胺纠正心源性休克有一定疗效。但在快速紧急纠正休克及增加心肌收缩力方面疗效欠佳。我科及监护病房(ICU)自1988年11月—1989年3月采用胰高血糖素及胰岛素治疗心源性休克及心肌缺血疗效显著,现报道于下: 临床资料本文治疗心源性休克9例,心肌缺血65例,共74例,男54例,女20例。年龄56—89岁,原发病:心源性休克9例中:急性心肌梗塞8例,过
Cardiac shock for acute severe illness, high mortality. In particular, patients with acute myocardial infarction occurred in 10-20% of cardiogenic shock, the mortality rate was 4-6 times higher than those without shock, is the current focus of coronary heart disease research. Previous use of dopamine, hydroxylamine or dobutamine to correct cardiogenic shock have a certain effect. However, it is ineffective in rapidly and promptly correcting shock and increasing myocardial contractility. Our department and intensive care unit (ICU) from November 1988 to March 1989 using glucagon and insulin treatment of cardiogenic shock and myocardial ischemia significant effect, are reported below: Clinical data in this paper, the treatment of cardiogenic shock 9 cases, 65 cases of myocardial ischemia, a total of 74 cases, 54 males and 20 females. Aged 56-89 years, the original disease: 9 cases of cardiogenic shock: acute myocardial infarction in 8 cases, too